We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
15 hedge funds and large institutions have $369K invested in Plus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
600% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 1
67% more funds holding
Funds holding: 9 → 15 (+6)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.33% less ownership
Funds ownership: 0.46% → 0.13% (-0.33%)
53% less capital invested
Capital invested by funds: $780K → $369K (-$411K)
Holders
15
Holders Change
+6
Holders Change %
+66.67%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
2
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
HRT Financial
New York
|
+$114K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$90K |
| 3 |
VF
Virtu Financial
New York
|
+$44.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$37.4K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$15.3K |
Top Sellers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$645K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.23K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$1.09K |
